Skip to content
FIND A HEALTH VALLEY ACTOR

Venture Leaders Biotech 2026: 10 innovative biotech startups selected for the Boston roadshow

Venture Leaders Biotech 2026

Ten startups, 4 of them from the Swiss Health Valley, have been selected for the 2026 Venture Leaders Biotech programme, which will take them to Boston from May 31st to June 5th as part of the Swiss National Startup Team. During their roadshow, the entrepreneurs will connect with international investors and industry leaders, acquiring expertise…

Read More

Dexterous Endoscopes receives CHF 150,000 from Venture Kick

Dexterous Endoscope

The EPFL spin-off Dexterous Endoscopes has obtained CHF 150,000 from Venture Kick to develop endoscopes with variable stiffness that provide surgeons with greater control and advanced tissue dissection capabilities. The medtech startup aims to enable new minimally invasive procedures in hard-to-reach areas within the sinuses and larynx, with future applications in other organs. Millions of…

Read More

The Swiss Data Science Center Opens Headquarters at Biopôle in Lausanne 

Swiss Data Science Center

The Swiss Data Science Center (SDSC) inaugurating its headquarters at the Biopôle campus in Lausanne, as part of a strategic partnership with the State of Vaud. This is the first time that SDSC has had a space independent of its partner institutions – EPFL, ETH Zurich, and PSI – thereby strengthening its presence in French-speaking…

Read More

Seprify Raised CHF 12.25 million in Series A Funding

Seprify

Seprify, a spin-off from the University of Fribourg and the University of Cambridge, now based at the Marly Innovation Centre (MIC), is a bio-materials company developing high-performance cellulose-based ingredients for industrial applications, announced the transition of its cellulose platform from pilot validation into procurement-ready industrial supply. This enables manufacturers to move from trials into repeatable…

Read More

Giannina Iannotti, from HUG NeuroCentre, Received the BCV 2025 Sustainability Award

Prix BCV

Giannina Iannotti, coordinator of the HUG NeuroCentre, received the BCV 2025 Sustainability Award, given to the HEC Lausanne Executive MBA strategic consulting project with the greatest impact in terms of sustainability. An academic project with real-world benefits The Optimising HUG Outpatient Care for Mild and Moderate Traumatic Brain Injury project proposes a sustainable model rooted…

Read More

Polares Medical Raises $50 million in Series C Funding

Polares Medical

The funding was supported by DC Global Ventures, Lumination Capital, existing investors and a new strategic investor, to help advance MRace‘s US expansion following strong clinical results. Polares Medical SA (‘Polares’), a Swiss Health Valley clinical-stage structural heart company developing the MRace mitral valve replacement system for mitral valve regurgitation (MR), announced the closing of…

Read More

Therapy Dogs Bring Comfort to Children with Cancer at CHUV

CHUV - Dog Therapy

Two therapy dogs have recently joined the daily life of children hospitalized in the Pediatric Hematology-Oncology Unit at the Children’s Hospital of Lausanne University Hospital (CHUV). This pilot initiative — the first of its kind in Switzerland within a pediatric oncology unit — represents an important step forward in integrating complementary therapies to support the…

Read More

Swiss MedTech Startup HeroSupport Secures CE Mark for VENUS SHELL™

HeroSupport

On International Women’s Day, HeroSupport, a University of Geneva spinoff, announced that its first medical device, VENUS SHELL™, has received CE Mark certification and is now authorised for marketing across the European Union and Switzerland.  The CE mark confirms compliance with all applicable EU health, safety, and environmental standards. It enables deployment in hospitals and…

Read More

Novigenix AI Spin-Out to Accelerate AI-Powered Immune Intelligence

Novigenix

Novigenix SA, a Swiss Health Valley leader in immunotranscriptomic diagnostics, announced the formal spin-out and launch of Novigenix AI, a new precision medicine company dedicated to transforming therapy development through AI-powered immune intelligence. A Strategic Separation to Unlock Two High-Growth Markets The new AI spin-out separates Novigenix’s colorectal cancer (CRC) screening business from its rapidly…

Read More

HUG Launch a Women’s Cardiovascular Health Center

HUG-Cardiovascular

The Hôpitaux universitaires de Genève (HUG) announce the creation of a new Women’s Cardiovascular Health Center, a dedicated initiative designed to improve the diagnosis, prevention, and treatment of cardiovascular diseases in women. Cardiovascular diseases remain the leading cause of death in Switzerland, accounting for approximately 20,000 deaths each year, according to the Federal Office of…

Read More